News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clovis Oncology (CLVS) Announces First Quarter 2013 Operating Results


5/7/2013 8:10:52 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for its first quarter ended March 31, 2013, and provided an update for its clinical development programs. This update describes, for the first time, the Company’s progress in developing a new formulation for CO-1686, including results from a recently initiated pharmacokinetic (PK) study in healthy human volunteers.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES